{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04231",
    "Peptide Name": "Brevinin-1BW (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL)",
    "Source": "skin,Pelophylax nigromaculatus, East Asia",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLPLLAGLAASFLPTIFCKISRKC",
    "Sequence Length": 24,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-inflammatory",
      "anti-sepsis",
      "Hemolytic",
      "Antibiofilm",
      "Anticancer"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -0.7,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "63%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is most similar (87.5%) toBrevinin-1EMbL: 21%, F=A: 13%. GRAVY: 1.191; mol wt: 2610.268; mol formula: C124H201N29O28S2; mol ex coeff: 125.Chemical modification:  C-terminus contains a Rana box: one disulfide bond.Activity: active against Gram+ E. faecalis ATCC 29212 (MIC 3.125 ug/ml), S. aureus ATCC 25923 or MDR ATCC 29213 (MIC 6.25 ug/ml), S. saprophytics ATCCBAA750 (MIC 6.25 ug/mL), S. epidermidis CI 1607BL1D39 (MIC 12.5 uM),  S. haemolyticus CI 1607BLD590 (MIC 12.5 ug/ml), Gram- E. coli ATCC 25922 (MIC 100 ug/ml), E. hormaechei ATCC700323 (MIC 100 ug/ml), P. aeruginosa ATCC 27853 (MIC 100 ug/ml), K.pneumoniae ATCC700603 (MIC >100 ug/ml), C. koseri CI 1611SED223 (MIC 50 ug/ml). Thus, mainly Gram+.  It also had an effect on biofilms:bacteria:S. aureus.Binds LPS and anti-inflammatary: TNF-alpha, IL-1bta,a nd IL-6 reduced due to peptide treatment at 4 ug/ml.Antimicrobial robustness: heat-stable: MIC didn't change after 1 h incubation at -20oC to 100oC.MOA:bacteria:S. aureus: MOA:bacteria:E. faecalis: membrane permeabilization and damage.Toxicity: sheep RBC: HC50 35.8 ug/ml. Also toxic to multiple non-cancer cells (IC50 28.34-43.62 ug/ml) and multiple cancer cells (IC50 23.79-39.2 ug/ml).",
    "Author": "Chen Z, Wang L, He D, Liu Q, Han Q, Zhang J, Zhang AM, Song Y. 2024",
    "Reference": "Molecules. 2024 Mar 29;29(7):1534. doi: 10.3390/molecules29071534.PubMed",
    "Title": "Exploration of the Antibacterial and Anti-Inflammatory Activity of a Novel Antimicrobial Peptide Brevinin-1BW."
  },
  "3D Structure": []
}